![Wesley Kaupinen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wesley Kaupinen
Founder at
Palvella Therapeutics, Inc.
Net worth: 190 M $ as of 2026-05-30
Profile
Wesley H.
Kaupinen is the founder of Palvella Therapeutics, Inc., founded in 2015, holding the titles of President, Chief Executive Officer & Director.
Mr. Kaupinen is also the founder of Palvella Therapeutics, Inc., founded in 2024, holding the titles of President, Chief Executive Officer & Director.
Former jobs include Director at Intact Vascular, Inc., Director at TELA Bio, Inc., Partner at Apax Partners, Inc., VP-Corporate Development & Commercialization at Insmed, Inc., Senior Associate at Quaker Partners Management LP from 2009 to 2011, Principal at Robertson Stephens, Inc., and Principal at Synthes Spine Co. Education includes undergraduate studies at the University of Virginia and an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
11.21% | 2026-02-04 | 1,607,228 ( 11.21% ) | 190 M $ | 2026-05-30 |
Wesley Kaupinen active positions
| Companies | Position | Start |
|---|---|---|
Palvella Therapeutics, Inc.
 Palvella Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing new therapeutic agents for diseases suffered by patients that lack any treatment choices | Founder | 2014-12-31 |
Former positions of Wesley Kaupinen
| Companies | Position | End |
|---|---|---|
Apax Partners, Inc.
 Apax Partners, Inc. Investment ManagersFinance Apax Partners focuses exclusively on long-term investments in growth companies. The firm invests globally in the following sectors: (1) financial and business services (2) healthcare (3) media (4) retail and consumer and (5) technology and telecommunications. They target large companies with strong, established market positions and the potential to expand. Apax Partners' investment strategy is to grow businesses by acting as a catalyst for change and to employ clear processes to maximize the value of their portfolio. | Private Equity Investor | 2005-12-30 |
| TELA BIO, INC. | Director/Board Member | - |
| INSMED INCORPORATED | Corporate Officer/Principal | - |
Intact Vascular, Inc.
 Intact Vascular, Inc. Medical SpecialtiesHealth Technology Develops medical devices for minimally invasive peripheral vascular procedures | Director/Board Member | - |
Robertson Stephens, Inc.
 Robertson Stephens, Inc. Investment Banks/BrokersFinance Brokerage | Corporate Officer/Principal | - |
Training of Wesley Kaupinen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
14
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Apax Partners, Inc.
Apax Partners, Inc. Investment ManagersFinance Apax Partners focuses exclusively on long-term investments in growth companies. The firm invests globally in the following sectors: (1) financial and business services (2) healthcare (3) media (4) retail and consumer and (5) technology and telecommunications. They target large companies with strong, established market positions and the potential to expand. Apax Partners' investment strategy is to grow businesses by acting as a catalyst for change and to employ clear processes to maximize the value of their portfolio. | Finance |
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Intact Vascular, Inc.
Intact Vascular, Inc. Medical SpecialtiesHealth Technology Develops medical devices for minimally invasive peripheral vascular procedures | Health Technology |
TELA Bio, Inc.
 TELA Bio, Inc. Medical SpecialtiesHealth Technology Operates as medical technology company, which designs, develops and markets tissue reinforcement materials to address unmet needs in soft tissue reconstruction | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quaker Partners Management LP
 Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management invests in healthcare companies located in the United States primarily in East Coast. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals and healthcare services. It participates in seed and early stage capital requirements. | Finance |
Robertson Stephens, Inc.
Robertson Stephens, Inc. Investment Banks/BrokersFinance Brokerage | Finance |
Synthes Spine Co.
 Synthes Spine Co. Medical SpecialtiesHealth Technology Offers implants and instruments for the treatment of fractures | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing new therapeutic agents for diseases suffered by patients that lack any treatment choices | Health Technology |
- Stock Market
- Insiders
- Wesley Kaupinen
